https://sputnikglobe.com/20201015/russia-can-register-third-covid-19-vaccine-in-one-month-public-health-watchdog-says-1080779256.html
Russia Can Register Third COVID-19 Vaccine in One Month, Public Health Watchdog Says
Russia Can Register Third COVID-19 Vaccine in One Month, Public Health Watchdog Says
Sputnik International
MOSCOW (Sputnik) - Russia can register its third vaccine against the coronavirus in a month, Anna Popova, the head of the national public health watchdog... 15.10.2020, Sputnik International
2020-10-15T12:21+0000
2020-10-15T12:21+0000
2020-10-15T12:25+0000
https://cdn1.img.sputnikglobe.com/img/07e4/09/15/1080528464_0:40:3073:1778_1920x0_80_0_0_ad3d0588c87484ae9c02af3b1f35aecd.jpg
russia
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2020
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, russia, vaccine, vaccine, coronavirus
newsfeed, russia, vaccine, vaccine, coronavirus
Russia Can Register Third COVID-19 Vaccine in One Month, Public Health Watchdog Says
12:21 GMT 15.10.2020 (Updated: 12:25 GMT 15.10.2020) MOSCOW (Sputnik) - Russia can register its third vaccine against the coronavirus in a month, Anna Popova, the head of the national public health watchdog, Rospotrebnadzor, said on Thursday.
"I want to say that the Russian Federation has two vaccines, and I'm sure that the third vaccine will be registered in a month”, Popova told the Russian Union of Industrialists and Entrepreneurs.
The statement was published after Russian President Vladimir Putin on Wednesday announced the registration of the second vaccine against the coronavirus, developed by the Vector centre. Phase 2 trials of the third vaccine, created by the Chumakov Federal Scientific Centre for Research, will start next week.
In August, Russia became the first country in the world to register a vaccine against COVID-19, dubbed Sputnik V and developed by the Gamaleya research institute. Gamaleya's drug requires two injections, using different adenoviral vectors, in order to form immunity from the coronavirus that can last up to two years.
